CME Group Inc. (CME) To Go Ex-Dividend on September 9th

CME Group Inc. (NASDAQ:CME) announced a quarterly dividend on Thursday, August 8th, RTT News reports. Shareholders of record on Monday, September 9th will be given a dividend of 1.15 per share by the financial services provider on Wednesday, September 25th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Monday, September 9th.

CME Group has increased its dividend by an average of 9.0% annually over the last three years and has increased its dividend every year for the last 14 years. CME Group has a dividend payout ratio of 45.8% indicating that its dividend is sufficiently covered by earnings. Analysts expect CME Group to earn $9.94 per share next year, which means the company should continue to be able to cover its $4.60 annual dividend with an expected future payout ratio of 46.3%.

CME Group Stock Up 0.5 %

CME Group stock opened at $220.50 on Friday. The firm has a market cap of $79.39 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 6.51 and a beta of 0.52. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $190.70 and a 52-week high of $223.80. The firm has a 50 day moving average price of $203.51 and a two-hundred day moving average price of $207.61.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.30 earnings per share. Equities analysts predict that CME Group will post 9.89 EPS for the current year.

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of several research reports. Barclays upped their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $212.00 to $177.00 in a research note on Tuesday. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $209.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.